Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,874 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
6-thioguanine-buried alive?
Herrlinger KR, Schwab M, Fellermann K, Stange EF. Herrlinger KR, et al. Among authors: schwab m. Gastroenterology. 2004 Mar;126(3):940-1; author reply 941-2. doi: 10.1053/j.gastro.2004.01.044. Gastroenterology. 2004. PMID: 14988863 No abstract available.
A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease.
Teml A, Schwab M, Hommes DW, Almer S, Lukas M, Feichtenschlager T, Florin T, Seiderer J, Petritsch W, Bokemeyer B, Kreisel W, Herrlinger KR, Knoflach P, Bonaz B, Klugmann T, Herfarth H, Pedarnig N, Reinisch W. Teml A, et al. Among authors: schwab m. Wien Klin Wochenschr. 2007;119(17-18):519-26. doi: 10.1007/s00508-007-0841-0. Wien Klin Wochenschr. 2007. PMID: 17943403
Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels.
Angelberger S, Schaeffeler E, Teml A, Petritsch W, Shonova O, Lukas M, Bar-Meir S, Dilger K, Greinwald R, Mueller R, Stange EF, Herrlinger KR, Schwab M, Reinisch W. Angelberger S, et al. Among authors: schwab m. Inflamm Bowel Dis. 2013 Mar;19(3):590-8. doi: 10.1097/MIB.0b013e31827eea8b. Inflamm Bowel Dis. 2013. PMID: 23388543
Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.
Reinisch W, Angelberger S, Petritsch W, Shonova O, Lukas M, Bar-Meir S, Teml A, Schaeffeler E, Schwab M, Dilger K, Greinwald R, Mueller R, Stange EF, Herrlinger KR; International AZT-2 Study Group. Reinisch W, et al. Among authors: schwab m. Gut. 2010 Jun;59(6):752-9. doi: 10.1136/gut.2009.194159. Gut. 2010. PMID: 20551460 Clinical Trial.
The pharmacogenetics of methotrexate in inflammatory bowel disease.
Herrlinger KR, Cummings JR, Barnardo MC, Schwab M, Ahmad T, Jewell DP. Herrlinger KR, et al. Among authors: schwab m. Pharmacogenet Genomics. 2005 Oct;15(10):705-11. doi: 10.1097/01.fpc.0000172242.19675.33. Pharmacogenet Genomics. 2005. PMID: 16141796
Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease.
Koslowski MJ, Kübler I, Chamaillard M, Schaeffeler E, Reinisch W, Wang G, Beisner J, Teml A, Peyrin-Biroulet L, Winter S, Herrlinger KR, Rutgeerts P, Vermeire S, Cooney R, Fellermann K, Jewell D, Bevins CL, Schwab M, Stange EF, Wehkamp J. Koslowski MJ, et al. Among authors: schwab m. PLoS One. 2009;4(2):e4496. doi: 10.1371/journal.pone.0004496. Epub 2009 Feb 16. PLoS One. 2009. PMID: 19221600 Free PMC article.
1,874 results